Gladstone NOW: The Campaign Join Us on the Journey✕
Maybe you've heard about CRISPR gene editing or stem cell therapy in the headlines—now you can find out what these and other technologies really mean for you. Can you imagine if your cells could be taken from a simple blood draw, reprogrammed in a lab dish, then infused back into your body to cure heart disease, treat Alzheimer’s, or shrink a cancer tumor? Or if a simple infusion could rewrite your genetic code to cure a DNA-driven disease? These scenarios may sound like science fiction, but such advances are happening now—forever changing our perspective of disease. No longer must we accept a dire health condition; we have the tools and technology to actually solve it for good.
Gladstone President Deepak Srivastava spoke at the Commonwealth Club World Affairs on February 4, 2025. This video was recorded and edited by the Commonwealth Club World Affairs.
Deepak Srivastava, MD, President, Gladstone Institutes
Robert Lee Kilpatrick, PhD, Chair, Health & Medicine Member-led Forum, Commonwealth Club World Affairs of California
Gladstone NOW: The Campaign
Join Us On The Journey
From fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin LabIn this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCsIn this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data